Skip to main content

Advertisement

SpringerLink
Log in

The heterogeneity of bone disease in cirrhosis: a multivariate analysis

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

This study aimed to assess the clinical, biochemical and hormonal factors contributing to low bone density in a large ambulatory group of patients with cirrhosis of diverse aetiology. Bone density of the lumbar spine, neck of femur, total hip, total body, as well as total body fat, was measured by dual X-ray (DEXA) absorptiometry in 81 men and 32 women (average age 50.3 years). Morning blood and urine samples were taken for hormonal and biochemical analysis. Viral hepatitis was the most common cause of cirrhosis (54%) and the severity of cirrhosis ranged from Child-Pugh A5–C14. Osteoporosis was most common in the lumbar spine but was present at any site in 31% of women and 22% of men, with osteopenia present in another 40% of both genders. Urinary deoxypyridinoline, a marker of bone resorption, was elevated in 56% of patients and was associated with increasing severity of cirrhosis and a higher prevalence of osteoporosis, particularly of the lumbar spine. Hip-bone density was primarily affected by low 25-hydroxyvitamin D levels and was associated with secondary hyperparathyroidism in one third of these patients. Additional important predictors for low bone density at all sites were age in women and testosterone in men. These findings indicate that, although the pathophysiology of osteoporosis in chronic liver disease is heterogeneous, high bone turnover may be the underlying pathophysiological mechanism in a significant subgroup of cirrhotic patients and may reflect metabolic effects of hypogonadism or secondary hyperparathyroidism on bone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2a–b.
Fig. 3a–d.

Similar content being viewed by others

References

  1. Collier J, Ninkovic M, Compston J (2002) Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 50 [Suppl 1]:1–-9

  2. Stellon A, Webb A, Compston J, Williams R (1987) Low bone turnover state in primary biliary cirrhosis. Hepatology 7:137–142

    CAS  PubMed  Google Scholar 

  3. Diamond T, Stiel D, Lunzer M, Eckstein R, Posen S (1989) Hepatic osteodystrophy: static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 96:213–221

    CAS  PubMed  Google Scholar 

  4. Guanabens N, Pares A, Brancos A, et al (1990) Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol 85:1356–262

    CAS  PubMed  Google Scholar 

  5. McDonald J, Dunstan C, Dilworth P, et al (1991) Bone loss after liver transplantation. Hepatology 14:613–619

    CAS  PubMed  Google Scholar 

  6. McCaughan G, Feller R (1994) Osteoporosis in chronic liver disease: pathogenesis, risk factors, and management. Dig Dis 12:223–231

    CAS  PubMed  Google Scholar 

  7. Hodgson S, Dickson E, Eastell R, Erikson E, Bryant S, Riggs B (1993) Rates of cancellous bone remodelling and turnover in osteopenia associated with primary biliary cirrhosis. Bone 14:819–827

    CAS  PubMed  Google Scholar 

  8. Hammond G, Nisker J, Jones L, Siiteri P (1980) Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration dialysis. J Biol Chem 255:5023–5026

    CAS  PubMed  Google Scholar 

  9. Hodgson S, Dickson E, Wahner H, Johnson K, Mann K, Riggs B (1985) Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 103:855–860

    CAS  PubMed  Google Scholar 

  10. Monegal A, Navasa M, Guanabens N, et al (1997) Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 60:148–154

    Article  CAS  PubMed  Google Scholar 

  11. Gallego-Rojo F, Gonzalez-Calvin J, Munoz-Torres M, Mundi J, Fernandez-Perez R, Rodrigo-Moreno D (1998) Bone mineral density, serum insulin-like growth factor and bone turnover markers in viral cirrhosis. Hepatology 28:695–699

    CAS  PubMed  Google Scholar 

  12. Herlong H, Recker R, Maddrey W (1982) Bone disease in primary biliary cirrhosis: histological features and response to 25-hydroxyvitamin D. Gastroenterology 83:103–108

    CAS  PubMed  Google Scholar 

  13. Cuthbert J, Pak C, Zerwekh J, Glass K, Combes B (1984) Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 4:1–8

    CAS  PubMed  Google Scholar 

  14. Coates P (1999) Clinical use of bone resorption markers. Clin Biochemist Rev 20:39–49

    Google Scholar 

  15. Ricard-Blum S, Bresson-Hadni S, Vuitton D, Ville G, Grimaud J (1992) Hydroxypyridinium collagen cross-links in human liver fibrosis: study of alveolar echinococcosis. Hepatology 15:599–602

    CAS  PubMed  Google Scholar 

  16. Conigrave A, Quinn S, Brown E (2000) L-amino acid sensing by the extracellular Ca2+ sensing receptor. Proc Natl Acad Sci USA 97:4814–4819

    CAS  PubMed  Google Scholar 

  17. Silverberg S, Fitzpatrick L, Bilezikian J. Primary hyperparathyroidism. In: Becker K (ed) Principles and practice of endocrinology and metabolism. Lipincott, Philadelphia, pp. 512–514

  18. Arnaud S (1981) 25-hydroxyvitamin D3 treatment of bone disease in primary biliary cirrhosis. Gastroenterology 83:137–149

    Google Scholar 

  19. Rouillard S, Lane N (2001) Hepatic osteodystrophy. Hepatology 33:301–307

    Article  CAS  PubMed  Google Scholar 

  20. Diamond T, D S, Mason R, et al (1989) Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease. J Clin Endocrinol Metab 69:1234–1239

    CAS  PubMed  Google Scholar 

  21. Stellon A, Webb A, Compston J, Williams R (1986) Lack of osteomalacia in chronic cholestatic liver disease. Bone 7:181–185

    CAS  PubMed  Google Scholar 

  22. Lips P, Obrant, KJ (1991) The pathogenesis and treatment of hip fractures. Osteoporosis Int 1:218–231

    CAS  Google Scholar 

  23. Lips P, Netelenbos J, Jongen M, van Giekel F, Althuis L, van Schaik C (1982) Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Relat Res 4:85–93

    CAS  PubMed  Google Scholar 

  24. Diamond T, Smerdly S, Kormas N, Sekel R, Vu T, Day P (1998) Hip fracture in elderly men: the importance of subclinical vitamin D deficiency and hypogonadism. Med J Aust 169:138–141

    CAS  PubMed  Google Scholar 

  25. Chapuy M-C, Preziosi P, Maamer M, et al (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis Int 7:439–443

    Article  CAS  Google Scholar 

  26. Tangpricha V, Pearce E, Chen T, Holick M (2002) Vitamin D insufficiency among free-living healthy young adults. Am J Med 112:659–662

    CAS  PubMed  Google Scholar 

  27. Gannage-Yared M, Chemali R, Yaacoub N, Halaby G (2000) Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res 15:1856–1862

    CAS  PubMed  Google Scholar 

  28. Vasikaran S, Sturdy G, Musk A, Flicker L (2000) Vitamin D insufficiency and hyperparathyroidism in Perth blood donors. Med J Aust 172:X06–-X7

    Google Scholar 

  29. McGrath J, Kimlin M, Saha S, Eyles D, Paris A (2001) Vitamin D insufficiency in south-east Queensland. Med J Aust 174:150–151

    CAS  Google Scholar 

  30. Heaf J. Hepatic osteodystrophy (1985) Scand J Gastroenterol 20:1035–1040

    Google Scholar 

  31. Compston J (1986) Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut 27:1073–1090

    CAS  PubMed  Google Scholar 

  32. Hay J (1995) Bone disease in cholestatic liver disease. Gastroenterology 108:276–283

    CAS  PubMed  Google Scholar 

  33. Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S (1990) Osteoporosis and skeletal fractures in chronic liver disease. Gut 31:82–87

    CAS  PubMed  Google Scholar 

  34. Baker H (1995) Testicular dysfunction in systemic disease. In: Becker K (ed) Principles and practice of endocrinology and metabolism. Lippincott, Philadelphia, p. 1085

  35. Burke C, Anderson D (1972) Sex hormone binding globulin is an estrogen amplifier. Nature 240:38

    CAS  PubMed  Google Scholar 

  36. Dawson-Hughes B, Shipp C, Sadowski L, Dallal G (1987) Bone density of the radius, spine and hip in relation to percent ideal body weight in postmenopausal women. Calcif Tissue Int 40:310–314

    CAS  PubMed  Google Scholar 

  37. Pocock N, Eisman J, Gwinn T, et al (1989) Muscle strength, physical fitness and weight but not age predict femoral neck bone mass. J Bone Miner Res 4:441–447

    CAS  PubMed  Google Scholar 

  38. Baker D, Roberts R, Towell T (2000) Factors predictive of bone mineral density in eating-disordered women: a longitudinal study. Int J Eat Disord 27:29–35

    Article  CAS  PubMed  Google Scholar 

  39. Selby P, Peacock M (1986) The effect of transdermal oestrogen on bone calcium-regulating hormones and liver in postmenopausal women. Clin Endocrinol Oxf 25:543–547

    CAS  PubMed  Google Scholar 

  40. O'Donohue J, Williams J (1997) Hormone replacement therapy in women with liver disease. Br J Obstet Gynaecol 104:1–3

    CAS  Google Scholar 

  41. Arver S, Dobs A, Meikle A, et al (1997) Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men. Clin Endocrinol 47:727–737

    CAS  Google Scholar 

  42. Matloff D, Kaplan M, Neer R, Goldberg M, Bitman W, Wolfe H(1982) Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Gastroenterology 83:97–102

    CAS  PubMed  Google Scholar 

  43. Van Berkum F, Beukers R, Birkenhager J, Kooij P, Schalm S, Pols H (1990) Bone mass in women with primary biliary cirrhosis: the relation with histological stage and the use of steroids. Gastroenterology 99:1134–1139

    PubMed  Google Scholar 

  44. Crippin J, Jorgensen R, Dickson E, Lindor K (1994) Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Am J Gastroenterol 89:47–50

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr. Sing Kai Lo, Institute of National Health, University of Sydney, for his assistance with statistical analysis.

Author information

Authors and Affiliations

  1. Department of Endocrinology, Royal Prince Alfred Hospital and University of Sydney, Camperdown, NSW 2050, Australia

    Bronwyn A. L. Crawford

  2. A.W. Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital and University of Sydney, Camperdown, NSW 2050, Australia

    C. Kam, A. J. Donaghy & G. W. McCaughan

Authors
  1. Bronwyn A. L. Crawford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Kam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. J. Donaghy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. W. McCaughan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bronwyn A. L. Crawford.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crawford, B.A.L., Kam, C., Donaghy, A.J. et al. The heterogeneity of bone disease in cirrhosis: a multivariate analysis. Osteoporos Int 14, 987–994 (2003). https://doi.org/10.1007/s00198-003-1495-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-003-1495-z

Keywords

Search

Navigation